FQ3’2021 Revenues Increased 294% Year-Over-Year to $1.7 Million
STONY BROOK, N.Y. – August 12, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, today announced consolidated financial results for the three and nine months ended June 30, 2021. “We delivered excellent year-over-year revenue growth [...]